Timing of SARS-CoV-2 Vaccination Matters in People With Multiple Sclerosis on Pulsed Anti-CD20 TreatmentArticle Published on 2022-10-122022-11-15 Journal: Neurology® neuroimmunology & neuroinflammation [Category] [DOI] 10.1212/NXI.0000000000200031 PMC 바로가기
Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccinesArticle Published on 2022-10-112022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.1018393 PMC 바로가기
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE networkArticle Published on 2022-10-082022-11-15 Journal: Trials [Category] [DOI] 10.1186/s13063-022-06791-y PMC 바로가기
Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case-control study (COVID-19VacRTX)Article Published on 2022-10-062022-11-15 Journal: Rheumatology (Oxford, England) [Category] [DOI] 10.1093/rheumatology/keac036 PMC 바로가기
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsArticle Published on 2022-10-062022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.1004045 PMC 바로가기
Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune responseArticle Published on 2022-10-012022-11-15 Journal: Journal of internal medicine [Category] [DOI] 10.1111/joim.13523 PMC 바로가기
Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination scheduleArticle Published on 2022-10-012022-11-15 Journal: Immunology letters [Category] [DOI] 10.1016/j.imlet.2022.09.001 PMC 바로가기
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicityArticle Published on 2022-10-012022-11-15 Journal: Clinical microbiology and infection : the official [Category] [DOI] 10.1016/j.cmi.2022.04.019 PMC 바로가기
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysisArticle Published on 2022-10-012022-11-15 Journal: Clinical microbiology and infection : the official [Category] [DOI] 10.1016/j.cmi.2022.05.009 PMC 바로가기
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritisArticle Published on 2022-10-012022-11-15 Journal: RMD Open [Category] [DOI] 10.1136/rmdopen-2022-002632 PMC 바로가기